Scientific approaches toward improving cervical cancer elimination strategiesMatti Lehtinen, Joakim Dillner, Iacopo Baussano et al.|International Journal of Cancer|2024Cited by 24
Low avidity of human papillomavirus (HPV) type 16 antibodies is associated with increased risk of low-risk but not high-risk HPV type prevalenceProscovia B. Namujju, Matti Lehtinen|BMC Research Notes|2011Cited by 11
Controlled trial of cervical cancer screening frequency among human‐papillomavirus‐vaccinated womenMònica Ortega Llobet, Matti Lehtinen, Penelope Gray et al.|International Journal of Cancer|2025Cited by 5
Elimination of cervical cancer by refined vaccination and screeningMatti Lehtinen, Joakim Dillner, Simopekka Vänskä et al.|International Journal of Cancer|2024Cited by 3